WESTMINSTER RADAR
Search
My MPs
Menu

Question follow-through · 13771

Chronic Obstructive Pulmonary Disease: Medical Treatments

To ask the Secretary of State for Health and Social Care, how many people are being treated for chronic obstructive pulmonary disease.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
12 Nov 2024
Target answer date
14 Nov 2024
Answer
18 Nov 2024 · 6 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 12 Nov 2024

    Question tabled

    To ask the Secretary of State for Health and Social Care, how many people are being treated for chronic obstructive pulmonary disease.

  2. 14 Nov 2024

    Target answer date

    Date supplied by the official written-questions record.

  3. 18 Nov 2024

    Answer published

    The Department does not hold this data. Most chronic obstructive pulmonary disease treatment will take place in the community, so this information will be held at a regional level.

Open official record

Official data retrieved 27 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Lung Cancer: Medical Treatments

13 Nov 2024 · To ask the Secretary of State for Health and Social Care, how many people were being treated for lung cancer in August 2024.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Sleep Apnoea

13 Nov 2024 · To ask the Secretary of State for Health and Social Care, what data his Department holds on the number of people diagnosed with sleep apnea in the last 12 months.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Hospices: Children and Young People

15 Nov 2024 · To ask the Secretary of State for Health and Social Care, whether he plans to review the funding model for hospices for children and young people as part of the 10-Year Health Plan for the NHS.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Endometriosis: Medical Treatments

18 Nov 2024 · To ask the Secretary of State for Health and Social Care, whether he has had discussions with the Department of Health in Northern Ireland on improving health outcomes for people on waiting lists for the treatment of endometriosis.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Cannabis: Medical Treatments

18 Nov 2024 · To ask the Secretary of State for Health and Social Care, what his Department's policy is on legalising medicinal cannabis.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Cancer: Drugs

20 Nov 2024 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his policies of proposals to end funding of IsaPD.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Hormone Replacement Therapy

20 Nov 2024 · To ask the Secretary of State for Health and Social Care, how many women have been newly prescribed hormone replacement therapy in the last 12 months.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Medicines and Healthcare products Regulatory Agency: Fees and Charges

25 Nov 2024 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of proposed reforms to the Medicines and Healthcare products Regulatory Agency's statutory fees structures on (a) the Agency, (b) industry, (c)

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Medicines and Healthcare products Regulatory Agency: Fees and Charges

25 Nov 2024 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of the proposed reform of Medicines and Healthcare products Regulatory Agency statutory fees on investment in the UK market by medical technolo

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Respiratory Diseases: Drugs

25 Nov 2024 · To ask the Secretary of State for Health and Social Care, if he will take steps to ensure Integrated Care Systems are resourced to provide medicines for (a) chronic obstructive pulmonary disease and (b) other life-threatening respiratory diseases.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Chronic Obstructive Pulmonary Disease: Health Services

25 Nov 2024 · To ask the Secretary of State for Health and Social Care, whether his Department plans to develop a respiratory action plan to support patients with chronic obstructive pulmonary disease.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

X-linked Hypophosphataemia

26 Nov 2024 · To ask the Secretary of State for Health and Social Care, how many people have been diagnosed with X-linked hypophosphatemia in the last two years.